1. Home
  2. MDGL vs ARCC Comparison

MDGL vs ARCC Comparison

Compare MDGL & ARCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$517.68

Market Cap

12.1B

Sector

Health Care

ML Signal

HOLD

Logo Ares Capital Corporation

ARCC

Ares Capital Corporation

HOLD

Current Price

$19.27

Market Cap

13.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDGL
ARCC
Founded
2011
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
12.1B
13.4B
IPO Year
2005
2004

Fundamental Metrics

Financial Performance
Metric
MDGL
ARCC
Price
$517.68
$19.27
Analyst Decision
Strong Buy
Buy
Analyst Count
12
11
Target Price
$674.45
$21.36
AVG Volume (30 Days)
249.4K
6.3M
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
10.28%
EPS Growth
41.32
N/A
EPS
N/A
0.13
Revenue
$180,133,000.00
N/A
Revenue This Year
$58.39
$5.77
Revenue Next Year
$48.55
$2.29
P/E Ratio
N/A
$147.35
Revenue Growth
N/A
N/A
52 Week Low
$265.00
$17.40
52 Week High
$615.00
$23.42

Technical Indicators

Market Signals
Indicator
MDGL
ARCC
Relative Strength Index (RSI) 52.63 59.72
Support Level $502.45 $18.78
Resistance Level $539.17 $19.43
Average True Range (ATR) 16.12 0.38
MACD -3.49 0.06
Stochastic Oscillator 37.27 85.54

Price Performance

Historical Comparison
MDGL
ARCC

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

About ARCC Ares Capital Corporation

Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.

Share on Social Networks: